Development of targeted therapy and immunotherapy for treatment of small cell lung cancer

Motonobu Saito1,2,3, Kouya Shiraishi1, Akiteru Goto4

  • 1Division of Genome Biology, National Cancer Center Research Institute, Tokyo.

Insights

Targeted therapies are effective in lung adenocarcinoma but not yet in small cell lung cancer due to rare driver gene identification. New targets like PARP, EZH2, DLL3, and PD-1/PD-L1 blockade show promise for SCLC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeted therapy improves outcomes in lung adenocarcinoma (LADC) by targeting EGFR mutations and ALK fusions.
  • Small cell lung cancer (SCLC) lacks standard targeted therapies due to infrequent identification of driver gene aberrations via next-generation sequencing.

Purpose of the Study:

  • To review potential gene aberrations for targeted therapy in SCLC.
  • To discuss the utility of immune checkpoint blockade therapy in SCLC.

Main Methods:

  • Review of current literature on SCLC molecular biology and therapeutic targets.
  • Analysis of identified druggable targets including PARP, EZH2, DLL3, and PD-1/PD-L1.

Main Results:

  • Several candidate druggable targets, including PARP, EZH2, and DLL3, have been identified for SCLC.
  • Immune checkpoint blockade targeting PD-1/PD-L1 is under investigation through numerous clinical trials for SCLC efficacy.

Conclusions:

  • Advances in molecular understanding reveal potential targeted therapies for SCLC.
  • Further research and clinical trials are crucial to establish targeted and immune blockade therapies as standard treatments for SCLC.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
634